The content on this website is intended solely for veterinarians and other animal health professionals.
By using this website, you confirm that the above applies to you.
Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs
Stockholm, February 7, 2024 – Intervacc AB (publ) announces that it, together with Moredun Scientific, has been awarded a grant from the Eurostars-3 programme covering approx. 50 % of the €1.7 million project to advance Intervacc’s prototype vaccine against...Intervacc announces changes in the Nomination Committee
Stockholm, December 21, 2023 – Intervacc AB (publ) announces that the company and the chairman of the board have been informed that Ulrika Enhörning, appointed by Swedbank Robur Fonder and Thomas Ehlin, appointed by Fjärde AP-fonden have resigned from the Nomination...The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses
Stockholm, December 11, 2023 – European experts on strangles, a highly contagious and serious infectious disease affecting horses, will on December 13th meet at the National Equestrian Centre at Flyinge to share experiences on the use of vaccination to prevent...Report from Extraordinary General Meeting in Intervacc
Stockholm, November 23, 2023 – Intervacc AB (publ) has at the request of a group of shareholders, which together control not less than one-tenth of all shares in the company, on 23 November 2023 held an Extraordinary General Meeting (“EGM”), at which the...Nyhetstjänster
